Sunday, January 7, 2018

Celgene Nears Deal to Buy Impact Biomedicines

Celgene is nearing a deal to buy cancer biotechnology concern Impact Biomedicines for as much as $7 billion, according to people familiar with the matter.

from WSJ.com: US Business http://ift.tt/2qxjVwK
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)